Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:CCI
NYSE:CCISpecialized REITs

Is Crown Castle (CCI) Offering Value After Multi Year Share Price Decline?

Wondering if Crown Castle is offering value at its current share price, or if it is a value trap? This article walks through what the numbers suggest without the hype. The stock last closed at US$86.11, with a 1.4% gain over the past week, a 2.6% decline over the last month, a 2.9% decline year to date, a 0.8% return over 1 year, a 29.2% decline over 3 years, and a 33.4% decline over 5 years. Recent attention on Crown Castle has been driven by ongoing interest in tower and infrastructure...
NYSE:DAVA
NYSE:DAVAIT

Endava (DAVA) Is Down 15.6% After Conservative Guidance Highlights Slower Growth And Cautious Demand – Has The Bull Case Changed?

In recent days, Endava reiterated its emphasis on complex digital transformation projects while issuing conservative guidance that reflects slower revenue growth and cautious enterprise demand. This shift in tone has prompted a more reserved stance from analysts, who are reassessing the company’s risk profile and longer-term growth narrative. With conservative guidance underscoring slower revenue growth, we’ll now examine how this development reshapes Endava’s broader investment narrative...
NYSE:SHO
NYSE:SHOHotel and Resort REITs

How Portfolio Pruning, Renovations, and Dividends At Sunstone Hotel Investors (SHO) Has Changed Its Investment Story

Over the past year, Sunstone Hotel Investors has benefited from a recovering lodging market, steady dividend growth, and active portfolio reshaping through asset sales and selective acquisitions in high barrier to entry locations. Management’s emphasis on ongoing renovations and asset repositioning to enhance competitive strength, supported by stable business and leisure travel demand, is increasingly central to the company’s long-term investment story. We’ll now examine how Sunstone Hotel...
TSX:TRP
TSX:TRPOil and Gas

Is It Too Late To Consider TC Energy (TSX:TRP) After Its Strong Multi‑Year Run?

If you are wondering whether TC Energy shares still offer value after their recent run, or if the price already reflects the story, this article walks through the key numbers so you can judge that for yourself. The stock last closed at C$81.02, with returns of 2.8% over 7 days, 6.3% over 30 days, 5.4% year to date, 26.1% over 1 year, 92.3% over 3 years and 120.0% over 5 years. These figures naturally raise questions about how much upside or downside may be left. Recent news around TC Energy...
NasdaqGS:ABCL
NasdaqGS:ABCLLife Sciences

Is AbCellera (ABCL) Trading Its Platform Identity For Higher-Stakes Clinical Ambitions?

AbCellera Biologics recently highlighted its transition from a service-focused antibody discovery platform to a clinical-stage biotech, with proprietary candidates ABCL635 and ABCL575 now in Phase 1 trials and more than 100 partnered programs contributing potential royalties. This shift toward owning drug assets, alongside a broad royalty portfolio that includes 18 clinical programs, marks a meaningful change in how AbCellera may create and capture value within biopharma. We’ll now examine...
NasdaqGS:ASTE
NasdaqGS:ASTEMachinery

Assessing Astec Industries (ASTE) Valuation After Strong Recent Share Price Performance

Recent performance snapshot for Astec Industries (ASTE) Astec Industries (ASTE) has drawn fresh attention after a strong run over the past year, with the stock showing positive returns over the past month, past 3 months, and year to date. See our latest analysis for Astec Industries. The recent 7 day share price return of 14.29% and 30 day share price return of 17.73% build on a year to date share price return of 22.03%, while the 1 year total shareholder return of 63.86% contrasts with a...
NasdaqGS:PRAX
NasdaqGS:PRAXBiotechs

Is Praxis Precision Medicines (PRAX) Now Pricing In Recent Pipeline Progress And Volatile Share Gains

If you are looking at Praxis Precision Medicines and wondering whether the recent excitement is already in the price, you are not alone. The stock closed at US$303.34, with a 9.5% gain over the last 30 days, a 5.9% return year to date, a 243.8% return over 1 year, a 366.0% return over 3 years, and a 62.0% decline over 5 years. Recent company specific news has kept Praxis in focus for investors and added context to these share price moves. Headlines around its pipeline progress, regulatory...
NasdaqGS:JBLU
NasdaqGS:JBLUAirlines

Is JetBlue Airways (JBLU) Now Attractive After Recent Share Price Rebound?

Wondering if JetBlue Airways at around US$5.96 is a bargain or a value trap? This article walks through what the current price really reflects. The stock has returned 18.3% over the last 7 days and 24.2% over the last 30 days, while the 1 year return is a 2.6% decline and the 5 year return is a 64.2% decline. This mix can change how investors think about both risk and potential reward. Recent coverage has focused on JetBlue's ongoing efforts to reshape its route network and cost base, as...
TSX:AQN
TSX:AQNIntegrated Utilities

Should Algonquin’s Shift to a Pure-Play Regulated Utility Model Require Action From TSX:AQN Investors?

In recent years, Algonquin Power & Utilities has sold its non-regulated renewable energy business and its stake in Atlantica Sustainable Infrastructure, using the proceeds to cut debt and concentrate on becoming a pure-play regulated utility while working through an active schedule of rate cases. Alongside these portfolio moves, the company has refreshed its leadership team with new CFO and COO appointments, sharpening investor attention on execution, earnings stability and the...
NasdaqGS:SHC
NasdaqGS:SHCLife Sciences

Assessing Sotera Health (SHC) Valuation After Recent Share Price Swings

Why Sotera Health is Back on Investors’ Radar Sotera Health (SHC) continues to attract attention after recent share price swings, with returns over the past month, past 3 months and year giving investors fresh data points to reassess the stock. See our latest analysis for Sotera Health. Recent trading has cooled slightly, with a 30 day share price return showing a 4.7% decline after a stronger 90 day gain of 13.84%. The 1 year total shareholder return of 29.35% highlights momentum that...
OB:LINK
OB:LINKSoftware

A Look At LINK Mobility Group Holding (OB:LINK) Valuation After The Q4 2025 Trading Update

Why LINK Mobility Group Holding (OB:LINK) is back on investor radars LINK Mobility Group Holding (OB:LINK) has drawn fresh attention after its Q4 2025 trading update, which paired softer organic growth with expanded CPaaS exposure, record customer contract wins and a year marked by three acquisitions. See our latest analysis for LINK Mobility Group Holding. The Q4 2025 update and the recent extraordinary general meeting come against a mixed price backdrop. The 1 day share price return was...
NasdaqGS:REYN
NasdaqGS:REYNHousehold Products

Reynolds Consumer Products (REYN) Margin Slippage Challenges Bullish Earnings Growth Narratives

Reynolds Consumer Products FY 2025 earnings snapshot Reynolds Consumer Products (REYN) has wrapped up FY 2025 with fourth quarter revenue of US$1.0 billion and basic EPS of US$0.56, alongside net income of US$118 million, putting fresh numbers behind the current US$23.91 share price. Over the past two reported fourth quarters, revenue has moved from US$1.0 billion in Q4 2024 to US$1.0 billion in Q4 2025, while basic EPS shifted from US$0.58 to US$0.56. This gives investors a clear view of how...
ASX:JIN
ASX:JINHospitality

Do Jumbo Interactive’s Governance Shifts And SaaS-Led Earnings Momentum Reveal A New Strategy For ASX:JIN?

Jumbo Interactive Limited previously announced that Company Secretary Kimberly Sue resigned for personal reasons and that Graeme Blackett was appointed as an additional Company Secretary, effective 29 January 2026. Alongside these governance changes, Jumbo reported strong first-half FY26 earnings growth supported by expanding SaaS, managed services, and recent prize-based giveaway acquisitions in the UK and USA. Next, we’ll explore how this earnings momentum, driven by SaaS and managed...
NYSE:CBT
NYSE:CBTChemicals

Cabot (CBT) Margin Compression Challenges Bullish Profitability Narratives In Q1 2026

Cabot (CBT) opened fiscal Q1 2026 with revenue of $849 million and basic EPS of $1.39, setting a clear snapshot of its latest trading quarter for investors focused on both the top and bottom line. Over recent periods, the company has seen quarterly revenue move from $955 million in Q1 2025 to $899 million in Q4 2025 and then to $849 million in Q1 2026, while basic EPS shifted from $1.69 to $0.79 to $1.39 across those same quarters, giving a mixed picture on earnings momentum as margins...
XTRA:TUI1
XTRA:TUI1Hospitality

How Investors May Respond To TUI (XTRA:TUI1) Analyst Upgrades and Rising Insider Share Purchases

In recent days, TUI AG has attracted renewed attention as several banks, including J.P. Morgan and Kepler Capital, reiterated positive analyst ratings, while corporate filings showed an uptick in insider share purchases. This combination of external analyst confidence and insiders increasing their holdings is drawing focus to TUI’s upcoming 10 February 2026 earnings release as a key test of current optimism. Against this backdrop, we’ll explore how rising insider buying shapes TUI’s...